FEDERALhearing transcript

Congressional Hearing on Tuberculosis in Southern Africa

Original title: COMBATING TUBERCULOSIS IN SOUTHERN AFRICA

January 1, 2018

tuberculosis global health southern africa infectious disease foreign aid

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing examines the effectiveness of U.S. global health funding and strategies in addressing the world's deadliest infectious disease, which disproportionately impacts Southern Africa.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Sub-Saharan African populations

These populations experience higher rates of tuberculosis infection and mortality compared to other global regions.

U.S. Centers for Disease Control and Prevention (CDC)

The agency provides expertise and data to inform U.S. global health policy and intervention strategies.

USAID

The agency is responsible for implementing global health programs and distributing aid related to tuberculosis treatment.

What changed

Last recorded activity January 1, 2018.

What's next

Next step not available in the current record.

Summary

This hearing transcript documents a 2018 Congressional subcommittee meeting focused on the high mortality rates of tuberculosis in Southern Africa. Experts from the CDC, State Department, and USAID provided testimony on the challenges of diagnosing and treating the disease, particularly in populations with HIV.

Key Facts

Tuberculosis was the deadliest infectious disease in the world in 2016, causing 1.7 million deaths.
In 2016, 44 percent of all global tuberculosis deaths occurred in the Africa region.
The Africa region accounted for 25 percent of all new tuberculosis cases in 2016.
The tuberculosis death rate in Africa is 72 per 100,000 infected, compared to 35 in Southeast Asia and 13 in the eastern Mediterranean.
Nearly 75 percent of people co-infected with HIV and tuberculosis in 2016 lived in sub-Saharan Africa.
Tuberculosis is curable if patients are diagnosed and follow a proper treatment regimen.
Millions of newly infected people go undiagnosed and untreated annually.
Multiple drug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis strains are emerging due to inappropriate or incomplete treatment.

Frequently Asked Questions

Why is tuberculosis considered a major global health threat?

It is the world's deadliest infectious disease, killing more people annually than HIV/AIDS and malaria combined.

Why is Southern Africa specifically highlighted?

The region experiences a disproportionate burden of the disease, accounting for 44 percent of global tuberculosis deaths despite representing only 25 percent of new cases.

What makes tuberculosis harder to treat in some cases?

The emergence of multiple drug-resistant (MDR) and extensively drug-resistant (XDR) strains, often caused by inappropriate or incomplete treatment regimens.

Why It Matters

The hearing examines the effectiveness of U.S. global health funding and strategies in addressing the world's deadliest infectious disease, which disproportionately impacts Southern Africa.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Drug-Resistant Strains

The hearing highlights a shift in concern toward drug-resistant strains (MDR/XDR) resulting from incomplete treatment regimens.

U.S. Centers for Disease Control and Prevention USAID

Connected Entities

personDeborah L. Birx“U.S. Global AIDS Coordinator and U.S. Special Representative for Global Health D”Map →

personChristopher H. Smith“Chairman of the Subcommittee on Africa, Global Health, Global Human Rights, and ”Map →

personIrene Koek“Senior Deputy Assistant Administrator, Global Health Bureau, USAID”Map →

personRebecca Martin“Director, Center for Global Health, U.S. Centers for Disease Control and Prevent”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz15
Current news / social attention level

Publisher tools